Amorepacific Invests in HIGHER Corp Aesthetics
Amorepacific Holdings announced on Wednesday, 31 July 2026, that it has signed a strategic investment agreement with HIGHER Corporation to collaborate on the development and commercialization of beauty and medical aesthetics products. The partnership will concentrate on creating skin boosters, cosmeceuticals, medical devices, and post‑treatment after‑care products intended for distribution through clinics and hospitals, as well as conducting joint research on ingredients and materials.
HIGHER Corporation, founded in 2021, specializes in injectable solutions for medical aesthetics. Its flagship brand, HILO WAVE, employs proprietary Dual Hybrid Complex (DHC) technology that combines high‑ and low‑molecular‑weight hyaluronic acid. The brand is active in Korea, Japan, Indonesia, and Vietnam.
Sangmok Lee, CEO of Amorepacific Holdings Corp, stated, "Through this partnership, we aim to bring together skin science and medical technology to develop innovative beauty solutions and deliver new experiences in the global beauty and medical aesthetics market." In Yong Kim, CEO of HIGHER Corporation, added that the partnership "represents an important milestone for HIGHER Corporation and reinforces our commitment to advancing medical aesthetics through science‑driven innovation."
Amorepacific continues to operate a portfolio of skincare, makeup, haircare, and wellness brands across Korea and international markets and maintains a cosmetics research laboratory for product development. The agreement did not disclose any financial terms of the investment.
This article was generated with AI support and reviewed by an editor.